How T cells and B cells contribute to autoimmune disease, why their balance matters, and how care plans aim to support immune regulation.
T cells and B cells are central players in the immune system. In autoimmune disease, their normal roles can shift toward attacking the body's own tissues.
Each cell type plays a distinct role.
Their balance defines immune behaviour.
Many therapies target these cells.
Each layer aims at the same goal.
Plans are personalized.
Care follows the science of immune cells.
When regulatory signals weaken, T cells and B cells can target the body's own tissues, producing the inflammation and antibody activity that drive autoimmune disease. Understanding this imbalance is the starting point for most modern autoimmune treatments.
Care plans for autoimmune disease are increasingly built around modulating T cell and B cell activity rather than only suppressing symptoms. This shift is what allows regenerative and immune-supportive approaches to be discussed alongside conventional therapy.
| Cell Type | Role | Care Layer | ||
|---|---|---|---|---|
| T cells | Coordinate | DMARDs | ||
| B cells | Antibodies | Biologics | ||
| Regulatory T | Balance | Lifestyle | ||
| Memory | Persistence | Long-term plan |
T cells and B cells sit at the heart of autoimmune disease, and most care plans are built around supporting their balance.